Inicio

    Se encuentra usted aquí

    • You are here:
      • Inicio > CRG 20th Anniversary Symposium: The value of fundamental research

CRG 20th Anniversary Symposium: The value of fundamental research

CRG 20th Anniversary Symposium: The value of fundamental researchCRG 20th Anniversary Symposium: The value of fundamental research

ALL_TABS

Program

Download the Program and the Book of Abstracts

Day 1 - 23rd March 2023

09h00 Welcome and Opening
Conductor: Elvan Böke and Arnau Sebé-Pedrós
  • Luis Serrano, Director of the CRG
  • Jordi Camí, Director of the PRBB
  • Ignasi López, Director of the Relations with Health and Research Institutions Area, 'la Caixa' Foundation
  • Laia de Nadal, Rector of the Universitat Pompeu Fabra
  • Manel Balcells, Catalan Minister of Health
09h30 CRG 20 years' celebration
  • Miguel Beato, Founder and former Director of the CRG
  • Andreu Mas-Colell, President of the Barcelona Institute of Science and Technology and former Catalan Minister of Economy of the Government of Catalonia 
  • Carmen Vela, Director of Collaborative Projects, Gold Standards Diagnostics and former State Secretary of Research, Development and Innovation of the Spanish Government
10h00 Colloquium "The value of fundamental science"

Moderator: Cristina Sáez, science journalist

1st part: Short talks about the successful experience of four local entrepreneurs

  • Carlos Buesa, CEO, Oryzon Genomics
  • Marie-Eve Beaulieu, cofounder and Chief Scientific Officer of Peptomyc SL, spun out from VHIO
  • Maria Lluch, founder and Chief Scientific Offier of Pulmobiotics, spun out from CRG, and CRG Alumni
  • Salvador Aznar-Benitah, founder and Scientific Advisor of Ona Therapeutics, spunt out from IRB Barcelona, researcher at IRB Barcelona and CRG Alumni
  • Evan Floden, CEO and Co-founder, Seqera Labs, spunt out from CRG, and CRG Alumni

2nd part: Debate with relevant stakeholders in the field of life sciences entrepreneurship
11h30 Coffee break
 
  Scientific Talks
Session 1 | Chair: Sara Sdelci
12h00 "Mechanism-based antisense therapeutics for genetic diseases and oncology"
Adrian Krainer, Cold Spring Harbor Laboratory, NY, US,
introduced by Fátima Gebauer
 
13h00 "Understanding cellular reprogramming in vivo"
Manuel Serrano, Cambridge Institute of Science, Altos Labs, Cambridge, UK,
introduced by Bernhard Payer
 
14h00 Lunch break
 
  Sesion 2 | Chair: Nick Stroustrup
 
15h00 "A single-cell isoform view of mouse and human brain OR progress through 12 years of failure in long-read sequencing."
Hagen Tilgner, Weill Cornell’s The Feil Family Brain and Mind Research Institute, New York, NY, US,
introduced by Roderic Guigó
 
15h30 "Engineering a bacterial chassis to treat respiratory diseases"
Maria Lluch, Pulmobiotics, Barcelona, Spain,
introduced by Luis Serrano
 
16h00 "Adventures with Argonautes"
Phillip Zamore, HHMI, RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, US,
introduced by Manuel Irimia
 
17h00 Coffee break
 
17h30 Speech by
Laia Arnal, Director General of Knowledge Society, Transfer and Territory, Department of Research and Universities, Government of Catalonia  
 
  Sesion 3 | Chair: Donate Weghorn
 
17h35 "Organoids to study regeneration and cancer"
Meritxell Huch, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany,
introduced by Susana de la Luna
 
18h00 "The Src oncoprotein; from avian model systems to human disease"
Sara A. Courtneidge, Oregon Health & Science University, Portland, OR, US,
introduced by Eva Novoa
 
19h00 Closing
  • Dr. Cristobal Belda, Director of the Instituto de Salud Carlos III, representing the Spanish Ministry of Science and Innovation

 

Day 2 - 24th March 2023

  Sesion 4 | Chair: Thomas Surrey
 
09h00 "Mechanism of a cold-induced epigenetic switch"
Caroline Dean, John Innes Centre, Norwich, UK,
introduced by Isabelle Vernos
 
10h00 "Mechanism of insulin granule biogenesis"
Julia von Blume, Yale School of Medicine, New Haven, CT,  US,
introduced by Vivek Malhotra
 
10h30 "Targeting PI 3-Kinase in Women’s Cancers- The Insulin Complication"
Lewis Cantley, Harvard Medical School, Dana Farber Cancer Institute, Boston, US,
introduced by Jorge Ferrer
 
11h30 Coffee break
 
  Sesion 5 | Chair: Renee Beekman
 
12h00 "Lgr5 Stem Cell-based organoids in human disease"
Hans Clevers, Roche Pharma Research & Early Development, Roche Innovation Center Basel,
F. Hoffmann-La Roche Ltd, Basel, Switzerland,
introduced by Pia Cosma
 
13h00 "Complex Systems: from CRG to EMBL…"
James Sharpe, EMBL Barcelona, Barcelona, Spain
introduced by Ben Lehner
 
13h30 "Engineering Synthetic Circuits with CRISPR-mediated gene regulation"
Yolanda Schaerli, University of Lausanne, Lausanne, Switzerland,
introduced by Mara Dierssen
 
14h00 Lunch break
 
  Sesion 6 | Chair: Lars Velten
 
15h00 "Systemic temporal regulation of tissue physiology by circadian rhythms during health and aging"
Salvador Aznar-Benitah, Institute for Research in Biomedicine, Barcelona, Spain,
introduced by Thomas Graf
 
15h30 "Seqera Labs: A Multiomics Data Analysis Business Based on Open Science"
Evan Floden, Seqera Labs, Barcelona, Spain,
introduced by Cedric Notredame
 
16h00 "A harmonious journey from fundamental research to nuts and bolts - the Solexa story"
Nick McCooke, Founding CEO of Solexa,
introduced by Mònica Morales
 
17h00 Wrap-up / Conclusions
  • Mafalda Dias and Jonathan Frazer, Junior Group Leaders, Computational Biology and Health Genomics